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Abstract
Introduction: C-reactive protein (CRP) levels are associated with cardiovascular disease and systemic inflammation. We
assessed whether CRP-associated loci were associated with serum CRP and retinal markers of microvascular disease, in Asian
populations.
Methods: Genome-wide association analysis (GWAS) for serum CRP was performed in East-Asian Chinese (N= 2,434) and
Malays (N = 2,542) and South-Asian Indians (N = 2,538) from Singapore. Leveraging on GWAS data, we assessed, in silico,
association levels among the Singaporean datasets for 22 recently identified CRP-associated loci. At loci where directional
inconsistencies were observed, quantification of inter-ethnic linkage disequilibrium (LD) difference was determined. Next,
we assessed association for a variant at CRP and retinal vessel traits [central retinal artery equivalent (CRAE) and central
retinal vein equivalent (CRVE)] in a total of 24,132 subjects of East-Asian, South-Asian and European ancestry.
Results: Serum CRP was associated with SNPs in/near APOE, CRP, HNF1A and LEPR (p-values #4.761028) after meta-analysis
of Singaporean populations. Using a candidate-SNP approach, we further replicated SNPs at 4 additional loci that had been
recently identified to be associated with serum CRP (IL6R, GCKR, IL6 and IL1F10) (p-values #0.009), in the Singaporean
datasets. SNPs from these 8 loci explained 4.05% of variance in serum CRP. Two SNPs (rs2847281 and rs6901250) were
detected to be significant (p-value#0.036) but with opposite effect directions in the Singaporean populations as compared
to original European studies. At these loci we did not detect significant inter-population LD differences. We further did not
observe a significant association between CRP variant and CRVE or CRAE levels after meta-analysis of all Singaporean and
European datasets (p-value .0.058).
Conclusions: Common variants associated with serum CRP, first detected in primarily European studies, are also associated
with CRP levels in East-Asian and South-Asian populations. We did not find a causal link between CRP and retinal measures
of microvascular disease.
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Introduction
Elevated serum C-reactive protein (CRP) level is a marker for
increased systemic inflammation [1] and is associated with both
macrovascular [i.e stroke and coronary heart disease (CHD)] [2–
3] and microvascular [i.e diabetic nephropathy and chronic kidney
disease (CKD)] [4–5] disease. CRP levels show significant
heritability [6]. Understanding the pathways involved in the
pathogenesis of elevated serum CRP may provide crucial insights
into the pathophysiology of vascular diseases. Genome-wide
association studies (GWAS) have successfully identified common
genetic variants at 22 different gene loci that are associated with
CRP levels [7–10]. However, several of these variants were
discovered after large-scale meta-analysis using only populations of
European ancestry [7]. As there are substantial differences in
mean serum CRP concentrations between ethnic groups [11], it is
important to understand the relevance of these recently identified
variants in influencing serum CRP levels in non-European
populations.
The causal link between CRP and vascular diseases is
controversial and it has been suggested that elevated serum CRP
may be a consequence of inflammatory processes that subse-
quently lead to disease outcomes [12]. While there is some
evidence for a pro-inflammatory and pro-artherogenic role for
CRP [13–14], a recent in vivo study showed no suggestion of
atherosclerotic plaque reduction in a CRP knock-out mouse model
[15]. Furthermore, common genetic variants associated with
serum CRP levels identified from GWAS were not associated with
major macrovascular outcomes such as myocardial infarction (MI)
or CHD [7–8]. In contrast, with respect to microvascular
pathology, a recent study identified a CRP gene variant that was
associated with CKD [16]. Nevertheless, data on the link between
serum CRP and evidence of microvascular variations is lacking.
In this study, we aimed to identify common genetic variants
associated with serum CRP levels among Asian populations (East-
Asian Chinese and Malays and South-Asian Indian populations)
from Singapore, using a genome-wide association study (GWAS)
approach. Leveraging on genome-wide data, we next sought to
assess, in silico, the relevance of recently identified variants, several
of which have been only detected using European populations [7],
to these Asian subjects. Finally, to clarify the role of serum CRP in
the pathogenesis of vascular disease, we determined whether a
genetic variant at the CRP gene locus was associated with changes
in retinal vessel traits, which have been found to be associated with
serum CRP levels, subclinical vascular pathology and clinical
cardiovascular outcomes [17–23].
Methods
Ethics Statement
Each cohort used in this study secured approval from their
respective institutional review boards, and all participants provid-
ed written informed consent in accordance with the Declaration of
Helsinki. In addition, for the Singaporean datasets, approval was
granted by the Singapore General Hospital Ethics Committee, the
Singapore Eye Research Institute Ethics Committee and the
National Health Group Domain Specific Review Board and the
genetic analysis was approved by the National University of
Singapore Institutional Review Board.
Study Samples
To assess for association with serum CRP level, data from 3
adult population-based datasets were utilized. Singapore Prospec-
tive Study 2 (SP2) is a cross-sectional study of adult Chinese
(N= 5,499), Malay (N= 1,405) and Asian-Indian (N= 1,138)
samples. Detailed methodology for SP2 has been previously
reported [24] and GWAS data was only available for adult
Chinese samples (N= 3,066) in SP2. Singapore Malay Eye Study
(SiMES) is a cross-sectional study of adult Malays (N= 3,280) [25].
GWAS data was available for 3,072 Malay samples from SiMES.
Singapore Indian Eye Study (SINDI) is a cross-sectional study of
adult Asian-Indians (N= 3,400) living in Singapore [26] and
GWAS data was available for 2,953 subjects.
For the association between the most strongly associated CRP
variant and retinal vessel traits, we used data available in all 3
Singaporean datasets. Subsequently, additional validation was
sought, in silico, from meta-analysis data of European samples
(N= 18,722) from the Blue Mountain Eye Study (BMES), Age
Gene/Environment Susceptibility - Reykjavik Study (AGES),
Atherosclerosis Risk in Communities Study (ARIC), Cardiovas-
cular Health Study (CHS) and the Rotterdam study, that had
recently performed a GWAS for retinal vessel traits as part of the
Cohorts for Heart and Aging Research in Genomic Epidemiology
(CHARGE) consortium [27].
Genotyping and Imputation
Genotyping and quality control procedures for SP2, SiMES and
SINDI have been previously described [28]. 3,066 Chinese adults
from SP2 were genotyped using the Illumina 1Mduov3
(N= 1,016), HumanHap 610Quad (N= 1,467) and Hap550 arrays
(N= 583). All SiMES Malay adults (N= 3,072) and all SINDI
Asian-Indian adults (N=2,953) were genotyped using HumanHap
610Quad arrays.
CRP-Associated Variants in Asian Populations
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Chip-wise QC procedures were conducted in a standardised
manner in all studies. Tables S1 and S2 in File S1 provide study-
specific details. Briefly, samples were excluded based on sample
call-rates (,95%) and extreme heterozygosities (,0.25 or .0.35)
(Table S1 in File S1). Identity-by-state measures were performed
by pair-wise comparison of samples to detect cryptic relatedness
(Table S1 in File S1). One sample from each relationship was
excluded from further analysis and where duplicate samples had
been genotyped in different SNP-arrays, samples from the denser
array were retained.
Population structure ascertainment to prevent confounding of
results, was done using principal component analysis (PCA) [29]
and analysing plots with four reference panels from International
Hapmap [30] and Singaporean Chinese, Malay and Asian-Indian
samples from the Singapore Genome Variation Project (SGVP)
[31]. Outliers with discordant ethnic membership from reported
ethnicities were subsequently detected and removed (Table S1 in
File S1). Samples with discrepant genetically-inferred and reported
genders were also removed (Table S1 in File S1). 2,434 SP2
samples, 2,542 SiMES samples and 2,538 SINDI samples were
available for statistical analysis after QC measures.
Details of quality-control measures for SNPs are provided in
Table S2 in File S1. Briefly, sex-linked and mitochondrial SNPs
were removed, together with gross HWE outliers (p-value
,161024). SNPs that were monomorphic or with a MAF less
than 5% and SNPs with low call-rates (,95%) were also excluded.
In SP2 where more than one chip was used for genotyping, the
Mantel-extension test was carried out and 62 SNPs with extreme
discrepancies in allele frequencies from samples genotyped on
different arrays were removed from analyses.
We imputed for additional genotypes in all datasets with
IMPUTE v0.5.0. [32] using a posterior probability of at least 0.90
and a call-rate of at least 95% for all imputed SNPs. Genotype
calls were based on HapMap East-Asian samples (CHB and JPT)
[30] for SP2 Chinese and to better capture local patterns of
haplotype variation, all four HapMap reference panels (CEU, YRI
and JPT+CHB) [34] for the Malay and Asian-Indian samples.
1,745,429 SNPs from SP2, 1,559,514 SNPs from SiMES and
1,527,744 SNPs from SINDI were available for subsequent
analyses after imputation and QC procedures (Table S2 in File
S1).
Main Outcome Variables
Serum C-reactive protein levels. Clinical measures from
the Singaporean datasets used in this study are presented in
Table 1. Venous blood was drawn following a 10-hour overnight
fast was drawn from SP2 samples and in the non-fasted state from
SiMES and SINDI. Serum CRP was measured in all sample
collections from frozen plasma stored at 280uC, using a particle-
enhanced immunoturbidimetric method implemented on a
Roche/Integra 400 Analyser (Roche Diagnostics, Rotkreuz,
Switzerland). Samples with CRP measures .10 mg/L (184
samples from SiMES, 44 samples from SP2 and 242 from SINDI)
that may indicate acute clinical inflammation were excluded from
subsequent analysis, as recommended by the Centers for Disease
Control and Prevention and the American Heart Association [33–
34]. Raw CRP values were normalised by log transformation and
used as the dependent variable in GWAS analyses.
Retinal markers of microcirculation. Central retinal vein
equivalent (CRVE) and central retinal artery equivalent (CRAE)
measures were similarly determined in all datasets. Digital fundus
photographs were taken using a retinal camera (Canon CRDGi
with a 10D SLR back; Canon, Tokyo, Japan) after pupil dilation.
Two retinal images were taken, according to the Early Treatment
for Diabetic Retinopathy Study (ETDRS) standard field 1 and
ETDRS standard field 2, centered on the optic disc and fovea,
respectively [34]. Retinal vascular caliber was measured with
computer-assisted software according to standardized protocols
[27,35–37]. Figure S1 in File S1 highlights retinal arteriolar and
venular calibers, summarized as CRAE and CRVE equivalent,
respectively from retinal fundus photograph that were used in the
study. Vessel measurements in each study were carried out by
trained graders, masked to study subjects’ characteristics. Image of
the right eye was used for measurements and when this was
unavailable or un-gradable (due to disease or when at least 6
measurements of arterioles or venules could not be measured), the
Table 1. Clinical measures in SiMES, SP2 and SINDI datasets used in study.
SP2 SiMES SINDI
Ethnicity Chinese Malay Asian-Indian
N 2434 2542 2538
% Males 46.6 49.5 51.1
Mean age (SD) 48.0 (11.25) 59.1 (11.04) 58.0 (10.07)
CRP [N*,Mean(SD)]/mg/L 2198, 1.5 (1.62) 2275, 2.5 (1.7) 2238, 2.7 (2.35)
CRVE [N,Mean(SD)]/mm 1411, 218.9 (20.23) 2230, 219.2 (22.61) 2390, 208.2 (19.93)
CRAE [N,Mean(SD)]/mm 1413, 144.8 (14.54) 2181, 141.3 (16.64) 2390, 144.6 (14.46)
BMI [N,Mean(SD)]/kg/m2 2431, 22.9 (3.39) 2522, 26.4 (5,11) 2531, 26.2 (5.03)
LDL-C [N,Mean(SD)]/mmol/L 2431, 3.1 (0.83) 2541, 3.5 (1.01) 2538, 3.3 (0.94)
HDL-C [N,Mean(SD)]/mmol/L 2432, 1.5 (0.36) 2541, 1.4 (0.33) 2537, 1.1 (0.30)
% diabetes{ 5.4 25.6 33.5
% hypertension` 34.7 68.5 78.7
% currently smoking 9.9 34.7 14.5
*Excluding 242 samples from SINDI, 190 samples from SiMES and 48 samples from SP2, respectively who had CRP values .10 mg/L.
{hypertension defined as history of hypertension or SBP.140 mmHg or DBP.90 mmHg.
`diabetes defined as participants with a history of diabetes mellitus or fasting glucose levels $7.0 mmol/L in SP2 and HbA1c levels $6.5% in non-fasting blood samples
and/or those with previous history in SiMES and SINDI.
doi:10.1371/journal.pone.0067650.t001
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left eye image was examined. All arterioles and venules crossing
through a specified zone 0.5–1 disc diameter away from the optic
disc margin were measured and summarized as the CRAE or
CRVE, respectively.
Exposure variables. Study participants’ demographic char-
acteristics, lifestyle factors and medical history were obtained using
a standardized questionnaire in the 3 Singaporean datasets. Age
was defined as the age at the time of clinical examination.
Cigarette smoking data was categorized into 2 categories as
current smokers and former or non-smokers. Height in meters (m)
and weight in kilograms (kg) were measured in all dataset and used
to derive body-mass index (BMI). An average of at least two
systolic blood pressures (SBP) and diastolic blood pressures (DBP)
measurements was taken and hypertension was defined as a
history of hypertension or SBP.140 mmHg or DBP.90 mmHg.
In SP2, fasting glucose and serum lipid concentrations were
analyzed using kits from Boehringer Mannheim Systems (Mann-
heim, Germany) and read on a BM/Hitachi 747 analyzer (Roche
Diagnostics, Corp. Indianapolis, USA). Glycosylated haemoglobin
(HbA1c) levels and serum lipids were measured in non-fasting
blood from SiMES and SINDI participants, using enzymatic
methods implemented in the Advia 2400 Chemistry System
(Siemens Medical Solutions Diagnostics, Deerfield, IL, USA). In
the SINDI dataset, non-fasting HbA1c and serum lipids were
measured with turbidimetric inhibition immonoassays using the
Roche-CobasH CE analyser (Roche Diagnostics, Germany),
respectively. Diabetes was defined as participants with a history
of diabetes mellitus in all datasets or fasting glucose levels
$7.0 mmol/L in SP2 or HbA1c levels $6.5% in non-fasting
blood samples in SiMES and SINDI.
Statistical Analysis
GWAS association analysis with serum C-reactive
protein. SNP-based trend tests for serum CRP associations
were carried out in a chip-wise manner in the 3 Singaporean
datasets. Associations between SNPs and CRP level were analysed
in an additive model and adjusted for age, sex and population
stratification (the first 2 principal components in SiMES and the
first 3 principal components in SINDI only). These analyses were
performed using the genome association toolset, SNPTEST
(version 1.1.5) [32]. For analyses of imputed SNPs, SNP
information scores were required to be at least 0.5. Genomic
control (GC) correction was applied to association results from
each chip, to further control for possible residual inflations.
Global genome-wide data from individual study results were
subsequently combined (N= 6,692) using the inverse variance-
weighted meta-analysis, assuming only a fixed effects model as the
first aim was to identify novel loci. Cochran’s Q with a Qp-value
cut-off ,0.1 was used to determine SNPs with between-study
heterogeneity [37]. All meta-analysis procedures were performed
using the meta package in STATA (version 8.2).
In silico replication analysis of previously reported
candidate SNPs. All recently discovered index serum CRP-
associated variants (35 SNPs from 22 loci) from GWAS studies [7–
10] were selected for in silico replication among the 3 Singaporean
datasets. 4 index SNPs [rs769449, rs3091244, rs1800961 and
rs10521222 at the APOE, CRP, hepatocyte nuclear factor 4
(HNF4A) and sal-like 1 (SALL1) gene loci, respectively] were not
genotyped or failed QC procedures or were not captured after
imputation procedures in all 3 Singaporean datasets (Table S3 in
File S1). At gene loci where multiple index SNPs were identified
[APOE, CRP, glucokinase regulator (GCKR), HNF1A, interleukin 6
receptor (IL6R) and LEPR] pair-wise linkage disequilibrium (LD)
was calculated using HapMap CHB and GIH panels. When LD
between SNPs were high (r2.0.8 in both HapMap CHB and GIH
panels), 1 tagging SNP was selected for in silico replication,
prioritised if the SNP was actually genotyped in the Singapore
datasets as compared to imputed SNPs (Table S3 in File S1).
To determine significance, consistency of effect direction with
previously reported GWAS data was ensured in the Singaporean
datasets and as these loci have been well-validated, a p-value
threshold ,0.05 was used. A Binomial test was used to assess over-
representation of significant associations compared to the expected
at a=0.05. For all replicating index SNPs, we repeated the meta-
analysis procedure using the more conservative random effects
model to more accurately estimate effect sizes from the different
ethnic groups (East-Asian Chinese and Malays and South-Asian
Indian datasets) that had been combined. A Cochran’s Qp-value
cut-off ,0.1 was used to determine SNPs with between-study
heterogeneity [37]. Further secondary analyses adjusting for
cardiovascular risk factors known to be associated with serum
CRP (BMI, LDL-C and HDL-C levels and diabetes, hypertension
and smoking status) [38–39] were also conducted to identify any
modifications in association levels at these specific loci.
At loci that showed effects in opposite directions in our study
(compared to initial European GWAS [7]), quantification of inter-
population linkage disequilibrium (LD) differences was performed
with varLD [40], using European (CEU) and East-Asian Chinese
(CHB) data from HapMap [30] and Chinese, Malay and Asian-
Indian reference panels from SGVP [31]. We further assessed for
inter-population directional differences in LD by R correlation of
regional SNPs (1 Mb region) in HapMap European (CEU), Han
Chinese (CHB) and Indian panels (GIH).
Association analysis with retinal vessel traits. Association
between serum CRP and retinal vessel traits (CRVE and CRAE)
were first assessed in the Singaporean datasets. Next, one CRP
variant that was genotyped in all Singaporean datasets and had the
strongest association with serum CRP levels in our study was
selected for assessment with retinal vessel traits (CRVE and CRAE).
Regression analyses of CRVE and CRAE in SP2, SiMES and
SINDI were further adjusted for age, sex and population
stratification (the first two principal components in SiMES and
the first three principal components in SINDI only), using STATA
(version 8.2). Further validation of any significant association was
sought from meta-analysis data of European populations that had
recently completed a GWAS for retinal vessel traits [27].
We subsequently calculated predicted magnitude of effect,
between the CRP variant and CRVE in the 3 Singaporean
datasets. Predicted increase of CRVE per CRP risk allele was
obtained by multiplying the observed beta of serum CRP (per CRP
risk allele) with the observed beta of CRVE per SD (standard
deviation) increase in serum CRP. Predicted and observed effect
estimates were subsequently compared for the increase per risk
allele. Power to detect the mean predicted increase in CRVE (from
SP2, SiMES and SINDI datasets) among datasets was calculated
using QUANTO [41].
Results
CRP, APOE, HNF1A and LEPR Variants were Associated
with Serum C-reactive Protein in Singaporean Asian
Datasets at Genome-wide Levels of Significance
Individual and meta-analysis GWAS results of SiMES, SP2 and
SINDI Asian cohorts revealed serum CRP-associated SNPs in or
near CRP, APOE, HNF1A and LEPR with genome-wide levels of
significance (meta-analysis p-value between 4.7461028 and
1.90610221, Table S4 in File S1). SNPs at these four loci
included the same index SNPs reported in recent GWAS studies
CRP-Associated Variants in Asian Populations
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[7–10], or were in at least moderate LD [r2.0.8 in Hapmap East-
Asian (CHB and JPT) and Indian (GIH) panels] with index SNPs
(rs11265260 and rs2794520 from CRP, rs2075650 and rs4420638
from APOE, rs7310409, rs1183910 and rs1169310 from HNF1A
and rs1892534 from LEPR), corroborating the initial findings at
these loci.
Variants at 4 Additional Gene Loci were Associated with
Serum C-reactive Protein and were Directionally
Consistent in the in silico Assessment of Singaporean
Asian Datasets
All recently identified serum CRP-associated variants [7–10]
that were combined in a fixed effect meta-analysis are indicated in
Table 2 (see Table S5 in File S1 for full table of all index SNPs in
individual datasets and after meta-analysis). In addition to the
CRP, APOE, HNF1A and LEPR loci, we detected significant
associations with serum CRP level for index SNPs at 6 additional
loci [IL6R, G protein-coupled receptor, family C, group 6,
member A (GPRC6A), GCKR, interleukin 6 (IL6), interleukin 1
family, member 10 (IL1F10) and protein tyrosine phosphatase,
non-receptor type 2 (PTPN2)] at more nominal levels of
significance (meta-analyses p-values between 5.0961025 and
0.036) (Table 2). Forest plots of all significant loci detected among
the Singaporean datasets are provided in Figure S2 in File S1.
At 2 variants, rs6901250 at GPRC6A and rs2847281 at PTPN2
(Table 2), direction of effects were observed to be opposite in our
Singaporean Asian datasets (as compared to the initial European
GWAS [7]). varLD scores of pair-wise comparisons between
different ethnic groups at these two gene regions did not indicate
LD differences that were significantly greater than the entire
genome (all regional scores,than 0.5 SD and thus, below the 67th
percentile of LD variations across the entire genome, Figure S3 in
File S1). We also did not detect any contiguous regions with at
least moderate LD (r correlation .0.6) with these 2 index SNPs
that had opposite directions of effect when comparing European
(CEU) and Chinese (CHB) or Indian (GIH) reference panels from
HapMap, at the GPRC6A and PTPN2 regions (data not shown).
Thus in total, we were able to replicate associations at 12 SNPs
from 8 (CRP, APOE, HNF1A, LEPR, IL6R, GCKR, IL6 and IL1F10)
of the 22 known previously-reported CRP-associated gene loci
with consistent beta directions, among the East-Asian and South-
Asian study subjects participants from Singapore (Binomial-test p-
value ,0.001 for over-representation of significant results,
a=0.05). Assuming independence, these 12 SNPs explain
approximately 4.05% of serum CRP variance in the Singaporean
populations studied (Table 3). QQ-plot of meta-analysis p-value
Table 2. Association results of index CRP loci (7–10) in Singaporean datasets.
SP2 (N=2,179) SiMES (N=2,275) SINDI (N=2,238)
Fixed-effect meta-analysis
(N=6,692)
rsid Gene Chr Position
Test
allele TAF* Beta p-value TAF Beta p-value TAF Beta p-value Beta p-value Qp-value
rs2075650 APOE 19 50087459 G 0.089 0.107 1.9861025 0.122 0.127 1.026102100.125 0.110 7.0761029 0.116 1.90610221 0.408
rs11265260 CRP 1 157966663 G 0.167 20.122 1.18610210 0.113 20.106 4.1361027 0.106 20.071 6.6661024 20.101 1.13610217 0.208
rs2794520 CRP 1 157945440 G 0.435 0.072 3.7661027 0.491 0.065 4.5061027 0.653 0.051 1.6461024 0.063 8.88610216 0.677
rs4420638 APOE 19 50114787 A 0.103 0.081 5.4261024 0.159 0.126 1.5461029 0.101 0.108 4.1461025 0.107 1.55610215 0.108
rs1183910 HNF1A 12 119905190 G 0.614 0.060 5.5661026 0.709 0.057 8.0961025 0.584 0.046 3.9661024 0.054 3.55610212 0.901
rs7310409 HNF1A 12 119909244 G 0.622 0.060 3.0161025 0.675 0.062 7.5461026 0.459 0.038 0.003 0.053 2.85610211 0.567
rs1169310 HNF1A 12 119923816 G 0.508 0.050 7.9161025 0.601 0.045 7.6561024 0.472 0.038 0.003 0.044 2.6161029 0.897
rs1892534 LEPR 1 65878532 T 0.877 20.045 0.036 0.779 20.067 2.6061025 0.496 20.036 0.005 20.047 1.2361027 0.480
rs4537545 IL6R 1 152685503 T 0.370 20.053 3.6661024 0.224 20.024 0.117 0.295 0.026 0.059 0.034 5.0961025 0.312
rs6901250{ GPRC6A 6 117220718 G 0.448 0.034 0.009 0.482 0.010 0.430 0.760 0.037 0.015 0.026 0.008 0.429
rs1260326 GCKR 2 27584444 T 0.478 0.021 0.144 0.394 0.020 0.132 0.201 0.026 0.101 0.022 0.008 0.919
rs2097677 IL6 7 22699364 G 0.863 20.034 0.071 0.895 20.045 0.033 0.778 20.013 0.388 20.027 0.009 0.656
rs6734238 IL1F10 2 113557501 A 0.083 20.039 0.080 0.110 20.038 0.074 0.362 20.017 0.194 20.026 0.009 0.510
rs2847281{ PTPN2 13 12811593 G 0.124 0.027 0.168 0.121 0.034 0.091 0.219 0.011 0.458 0.022 0.036 0.864
rs2836878 PSMG1 21 39387404 A 0.835 20.021 0.267 0.861 20.012 0.538 0.775 20.024 0.108 20.020 0.052 0.980
rs12239046 NLRP3 1 245668218 T 0.381 0.009 0.523 0.357 0.006 0.629 0.420 0.029 0.025 0.015 0.052 0.387
rs340029 RORA 15 58682257 T 0.903 20.014 0.559 0.866 20.016 0.398 0.608 20.021 0.098 20.019 0.054 0.993
rs10745954 ASCL1 12 102007224 G 0.794 0.023 0.140 0.823 20.015 0.394 0.593 0.024 0.066 0.014 0.105 0.119
rs10778213 12 102019281 T 0.147 20.014 0.470 0.184 0.015 0.384 0.451 20.028 0.026 20.013 0.147 0.085
rs4903031 RGS6 14 72088989 G 0.156 20.043 0.028 0.249 0.014 0.343 0.327 20.014 0.286 20.010 0.258 0.046
rs4705952 IRF1 5 131867518 G 0.554 20.013 0.366 0.462 0.005 0.728 0.396 20.019 0.197 20.009 0.279 0.405
rs13233571 BCL7B 7 72609167 T 0.092 0.008 0.709 0.117 20.004 0.833 0.063 20.035 0.187 20.008 0.562 0.807
22 SNPs were genotyped or imputed and passed QC procedures in all 3 datasets and were combined in a meta-analysis (see Table S5 in File S1 for full results).
Significant results (p-value ,0.05) in bold.
TAF: Test allele frequency. { Variants which were significant but not directionally consistent with previous European study (7).
*Mean allele frequency from 3 SNP-chips used for the SP2 study. Qpvalue ,0.1 indicates between study heterogeneity.
doi:10.1371/journal.pone.0067650.t002
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associations after excluding SNPs around (100 kb upstream and
downstream) the 22 previously identified CRP-associated gene
loci, did not show an excess of small p-values (Figure S4 in File S1).
Further assessment of these 12 loci through meta-analysis
performed assuming the random effects model (at these specific
SNPs) indicated reduced association levels at several SNPs
(rs11265260, rs1892534 and rs7310409) but the same set of 12
SNPs remained significant (Table 3). Moreover, adjustment for
other cardiovascular risk factors did not abolish these associations
(p-value between 3.69610224 and 0.013, Table 3).
2 additional index variants, rs10778213 and rs4903031, showed
heterogeneity (Qpvalue,0.1) in the meta-analysis of all 3 Sinagpor-
ean datasets (Table 2). For each of these variants, the direction of
effect in the SiMES Malay subjects was opposite to that of the
Chinese (SP2) and Asian-Indian (SINDI) ethnic groups.
C-reactive Protein Increasing Variant (rs2794520) is not
Associated with Retinal Microvascular Caliber
We selected one index CRP SNP, rs2794520, that had been
directly genotyped in all Singaporean datasets and had the
strongest association with serum CRP levels in our meta-analysis
(rs2794520, p-value = 8.88610216 in both fixed and random-effect
models, Tables 2 and 3), for assessment with CRVE and CRAE
traits.
In all the 3 Singaporean Asian datasets, serum CRP was
associated with the CRVE phenotype (p-value #6.5661024,
Figure 1) and the CRP increasing allele (G allele) of rs2794520 was
marginally significant for increased CRVE (p-value between 0.048
and 0.022) but, this association was not replicated in the larger
CHARGE consortium European samples and overall meta-
analysis revealed no statistical significance (Table 4). No significant
associations were detected for CRAE in any of the datasets
(Table 4).
Power to detect changes of 0.45 mm in CRVE (mean predicted
effect estimates in SP2, SiMES and SINDI datasets, Figure 1),
assuming a minor allele frequency (MAF) of 40% (mean MAF of
rs2794520 in SP2, SiMES and SINDI) (a=0.05) was estimated to
be low in individual Singaporean datasets and only adequate after
meta-analysis of all Singaporean and European datasets (Table 4).
Observed effect sizes for CRVE per increase in risk allele of
rs2794520 were also 3–4 folds larger than expected among the
Singaporean datasets (Figure 1).
Discussion
Leveraging on GWAS data from 6,692 pan-Asian subjects,
comprising of Chinese and Malay East-Asian and South-Asian
Indian populations living in Singapore, we have shown that at
least 8 genetic variants, initially identified in primarily European
population studies, show similar associations with serum CRP.
Furthermore, at these loci, genetic associations with serum CRP
levels were observed to be independent of other known
cardiovascular risk factors, while the replications of LEPR, IL6R
and IL1F10 among East-Asians and the replications of GCKR, IL6
and ILF10 among South-Asians were novel.
Marginal associations at 2 loci (rs6901250 at the GPRC6A locus
and rs2847281 at the PTPN2 locus) where we detected effect
directions that were opposite to those identified in populations of
European ancestry were likely to be false positive findings and our
examination of inter-ethnic population LD differences did not
reveal significant results. Further large-scale studies in East-Asian
populations would be necessary to firmly confirm or dismiss
associations at these loci.
A unique aspect of our study, in the assessment of causality with
serum CRP, was the use of retinal vascular caliber (CRAE and
CRVE), which are markers for systemic microvasculature and
have been associated with subclinical and clinical cardiovascular
disease [18–23]. Previous large-scale Mendelian randomisation
studies did not detect an association between CRP variants and
CHD or MI [7–8,12]. Nevertheless, it is possible that the
heterogeneous nature of such end-stage disease outcome measures
may have masked true associations [42]. Furthermore, a recent
Table 3. Additional association analyses for 12 index CRP loci (7–10) that were significant (fixed-effect meta-analysis p-value
,0.05) in the Singaporean datasets and showed consistent direction of effect estimates.
Fixed-effect meta-
analysis*(N=6,692)
Random-effect meta-analysis
(N=6,692)
rsid Gene Chr Position Test allele Beta* p-value* Beta p-value Qp-value
Variance
explained (%)
rs2075650 APOE 19 50087459 G 0.124 3.69610224 0.116 1.90610221 0.408 0.70
rs11265260 CRP 1 157966663 G 20.107 3.54610220 20.100 5.53610211 0.208 0.68
rs2794520 CRP 1 157945440 G 0.069 3.05610219 0.063 8.88610216 0.677 0.45
rs4420638 APOE 19 50114787 A 0.123 1.75610222 0.107 1.55610215 0.108 0.62
rs1183910 HNF1A 12 119905190 G 0.061 1.13610216 0.054 3.55610212 0.901 0.33
rs7310409 HNF1A 12 119909244 G 0.060 2.22610216 0.053 5.91610211 0.567 0.30
rs1169310 HNF1A 12 119923816 G 0.048 1.22610212 0.044 2.6161029 0.897 0.26
rs1892534 LEPR 1 65878532 T 20.045 4.2761028 20.048 1.1561026 0.480 0.23
rs4537545 IL6R 1 152685503 T 20.035 8.0961026 20.034 5.0961025 0.312 0.20
rs1260326 GCKR 2 27584444 T 0.022 0.008 0.022 0.008 0.919 0.10
rs2097677 IL6 7 22699364 G 20.032 7.5161024 20.027 0.009 0.656 0.10
rs6734238 IL1F10 2 113557501 A 20.023 0.013 0.026 0.009 0.510 0.08
Significant results (p-value ,0.05) in bold.
*Additional covariates include BMI, BP, LDL-C, HDL-C and diabetes and smoking status. Qpvalue ,0.1 indicates between study heterogeneity. Variance explained: mean
variance from all 3 Singaporean datasets.
doi:10.1371/journal.pone.0067650.t003
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association of CRP variants with CKD [16] highlighted the need to
assess the role of CRP in microvascular disease, which has not
been tested in previous studies.
In our study, although serum CRP was associated with CRVE
levels, we do not find evidence to support a causal link between
serum CRP and changes in retinal vascular caliber. It is
noteworthy however, that marginally significant associations were
detected between the CRP variant and CRVE in only the
Singaporean Asian datasets (SP2 Chinese, SiMES Malays and
SINDI Asian-Indians) but not among the European samples
assessed. Although this may highlight an ethnic specific role, we
were inadequately powered to detect such associations in the
smaller Singaporean datasets and moreover, the association levels
in the Singaporean datasets were nominal and observed CRVE
effect sizes exceeded predicted estimates in all 3 Singaporean
datasets, indicating that these associations may be stochastic.
Furthermore, to prevent possible heterogeneity of assessing
multiple SNPs, we limited this analysis to one index SNP
(rs2794520 from the CRP gene locus), used as a proxy for serum
CRP. However, although highly significant, this SNP only
explained approximately 0.45% of the CRP phenotypic variance
among the Singaporean datasets. Repeating the analysis using all
12 CRP-associated SNPs that replicated in the Singaporean meta-
analysis (Table 2), with a gene-score method, did not improve the
association between genetic variants and CRVE (data not shown).
A weakness of our study was the modest sample size for
replication of serum CRP associations in East-Asian and South-
Asian populations and it is likely that we lacked sufficient power to
detect all true-positives, especially those with weaker effect sizes
that were first detected only after large-scale meta-analyses (in
European GWAS studies). Using an effect size of 1.35 mg/L
increase in serum CRP (approximate effect size the GPCR6A and
PTPN2 variants in a recent large-scale European GWAS [7]), we
estimated that a sample size of approximately 60,000 participants
would be necessary to be at least 80% powered (a=0.05) to detect
variants of similar magnitude in our Singaporean Chinese, Malay
and Asian-Indian datasets. Furthermore, although we increased
power to detect associations by combining datasets in our meta-
analyses, the diverse nature of the populations assessed may have
contributed to between-study heterogeneity. However, it was
reassuring that the same set of serum CRP-associated index SNPs
remained statistically significant in the meta-analyses of datasets
under the random effects model.
In conclusion, our meta-analysis of East-Asian and South-Asian
subjects, who constitute the major portion of populations in Asia,
wherein the burden of CVD is substantially increasing [43–44],
replicates and corroborates at least 8 serum CRP-associated gene
Figure 1. Comparison of observed and expected association results for rs2794520 and CRVE in A) SP2, B) SiMES and C) SINDI
datasets. Observed regression values presented in black and estimated values presented in gray. Regression models were adjusted for age and sex
in SP2 and age, sex and population stratification (first 2 principal components in SiMES and first 3 principal components in SINDI only).
doi:10.1371/journal.pone.0067650.g001
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loci. However, we do not find evidence to support a causal link
between serum CRP and markers for microvascular caliber.
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